Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Valneva is a specialty vaccine company headquartered in France. The company develops and commercializes innovative prophylactic vaccines against infectious diseases with significant unmet medical needs. Valneva covers the entire process from research and development to final product distribution.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Valneva is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Valneva last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 EUR.
Across its last 3 earnings reports, Valneva stock moved by ±1.3% on average the following day. The largest reaction was +1.9% on 05/13/2026; 2 of 3 reactions were positive.
Valneva has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.